{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:21:14Z","timestamp":1783041674270,"version":"3.54.6"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":157,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001773","name":"The University of New South Wales","doi-asserted-by":"crossref","award":["University Postgraduate Award"],"award-info":[{"award-number":["University Postgraduate Award"]}],"id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Garvan Institute of Medical Research","award":["Garvan Support Award"],"award-info":[{"award-number":["Garvan Support Award"]}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["#2017325"],"award-info":[{"award-number":["#2017325"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["#2026430"],"award-info":[{"award-number":["#2026430"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["#2010156"],"award-info":[{"award-number":["#2010156"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"publisher","award":["IIRS-22-060"],"award-info":[{"award-number":["IIRS-22-060"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","award":["RG-24-01"],"award-info":[{"award-number":["RG-24-01"]}],"id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immune infiltration is now recognised as an important prognostic factor in triple negative breast cancer (TNBC). DNA methylation, due to its cell-type specificity, offers a promising approach for quantifying immune cell abundance as a biomarker for risk stratification. Here, we used EpiDISH, a DNA methylation-based cellular deconvolution method, to estimate immune cell proportions from genome-wide methylation data across four independent breast cancer datasets. We show that increased methylation-estimated immune cell percentage in TNBC patients is associated with improved outcomes. This highlights the potential of DNA methylation-based estimates of cell composition for prognosis in TNBC.<\/jats:p>","DOI":"10.1186\/s13148-026-02052-w","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T01:45:08Z","timestamp":1769478308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DNA methylation estimates of immune cell abundance have prognostic potential in triple negative breast cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Sarah","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Korbie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Trau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Avery-Kiejda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braydon","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Southey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Antoine","family":"Dugu\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Stirzaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Pidsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"8","key":"2052_CR1","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","volume":"186","author":"E Nolan","year":"2023","unstructured":"Nolan E, Lindeman GJ, Visvader JE. Deciphering breast cancer: from biology to the clinic. Cell. 2023;186(8):1708\u201328.","journal-title":"Cell"},{"issue":"28","key":"2052_CR2","doi-asserted-by":"publisher","first-page":"46652","DOI":"10.18632\/oncotarget.16938","volume":"8","author":"AA Jitariu","year":"2017","unstructured":"Jitariu AA, Cimpean AM, Ribatti D, et al. Triple negative breast cancer: the kiss of death. Oncotarget. 2017;8(28):46652\u201362.","journal-title":"Oncotarget"},{"issue":"8","key":"2052_CR3","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris MA, Savas P, Virassamy B, et al. Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer. 2024;24(8):554\u201377.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2052_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1200\/JCO.18.01010","volume":"37","author":"S Loi","year":"2019","unstructured":"Loi S, Drubay D, Adams S, et al. Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers. J Clin Oncol. 2019;37(7):559\u201369.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2052_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","volume":"19","author":"C Denkert","year":"2018","unstructured":"Denkert C, von Minckwitz G, Darb-Esfahani S, et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2018;19(1):40\u201350.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2052_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41523-021-00346-1","volume":"7","author":"K El Bairi","year":"2021","unstructured":"El Bairi K, Haynes HR, Blackley E, et al. The tale of TILs in breast cancer: a report from the international immuno-oncology biomarker working group. NPJ Breast Cancer. 2021;7(1):150.","journal-title":"NPJ Breast Cancer"},{"key":"2052_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.01150","volume":"10","author":"WJ Locke","year":"2019","unstructured":"Locke WJ, Guanzon D, Ma C, et al. DNA methylation cancer biomarkers: translation to the clinic. Front Genet. 2019;10:1150.","journal-title":"Front Genet"},{"issue":"1","key":"2052_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12859-017-1511-5","volume":"18","author":"AE Teschendorff","year":"2017","unstructured":"Teschendorff AE, Breeze CE, Zheng SC, et al. A comparison of reference-based algorithms for correcting cell-type heterogeneity in Epigenome-Wide Association Studies. BMC Bioinformatics. 2017;18(1):105.","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"2052_CR9","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1093\/bioinformatics\/btz833","volume":"36","author":"SC Zheng","year":"2019","unstructured":"Zheng SC, Breeze CE, Beck S, et al. EpiDISH web server: epigenetic dissection of intra-sample-heterogeneity with online GUI. Bioinformatics. 2019;36(6):1950\u20131.","journal-title":"Bioinformatics"},{"issue":"1","key":"2052_CR10","doi-asserted-by":"publisher","first-page":"8167","DOI":"10.1038\/s41467-024-52283-9","volume":"15","author":"D Martino","year":"2024","unstructured":"Martino D, Kresoje N, Amenyogbe N, et al. DNA Methylation signatures underpinning blood neutrophil to lymphocyte ratio during first week of human life. Nat Commun. 2024;15(1):8167.","journal-title":"Nat Commun"},{"issue":"1","key":"2052_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13073-023-01211-5","volume":"15","author":"Q Luo","year":"2023","unstructured":"Luo Q, Dwaraka VB, Chen Q, et al. A meta-analysis of immune-cell fractions at high resolution reveals novel associations with common phenotypes and health outcomes. Genome Med. 2023;15(1):59.","journal-title":"Genome Med"},{"issue":"1","key":"2052_CR12","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1038\/s41467-020-17537-2","volume":"11","author":"D Glodzik","year":"2020","unstructured":"Glodzik D, Bosch A, Hartman J, et al. Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers. Nat Commun. 2020;11(1):3747.","journal-title":"Nat Commun"},{"key":"2052_CR13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ebiom.2018.04.025","volume":"31","author":"Y Gao","year":"2018","unstructured":"Gao Y, Widschwendter M, Teschendorff AE. DNA methylation patterns in normal tissue correlate more strongly with breast cancer status than copy-number variants. EBioMedicine. 2018;31:243\u201352.","journal-title":"EBioMedicine"},{"issue":"1","key":"2052_CR14","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1038\/s41467-024-48466-z","volume":"15","author":"K De Ridder","year":"2024","unstructured":"De Ridder K, Che H, Leroy K, et al. Benchmarking of methods for DNA methylome deconvolution. Nat Commun. 2024;15(1):4134.","journal-title":"Nat Commun"},{"issue":"6","key":"2052_CR15","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/ije\/dyx085","volume":"46","author":"RL Milne","year":"2017","unstructured":"Milne RL, Fletcher AS, MacInnis RJ, et al. Cohort Profile: The Melbourne Collaborative Cohort Study (Health 2020). Int J Epidemiol. 2017;46(6):1757\u20131757i.","journal-title":"Int J Epidemiol"},{"key":"2052_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-020-0145-3","volume":"6","author":"MJ Fackler","year":"2020","unstructured":"Fackler MJ, Cho S, Cope L, et al. DNA methylation markers predict recurrence-free interval in triple-negative breast cancer. NPJ Breast Cancer. 2020;6:3.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"2052_CR17","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1038\/s41598-021-83913-7","volume":"11","author":"KE Craven","year":"2021","unstructured":"Craven KE, Gokmen-Polar Y, Badve SS. CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer. Sci Rep. 2021;11(1):4691.","journal-title":"Sci Rep"},{"issue":"5","key":"2052_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2025.100736","volume":"38","author":"YJ Cha","year":"2025","unstructured":"Cha YJ, O\u2019Connell CE, Calhoun BC, et al. Genomic characteristics related to histology-based immune features in breast cancer. Mod Pathol. 2025;38(5):100736.","journal-title":"Mod Pathol"},{"issue":"1","key":"2052_CR19","doi-asserted-by":"publisher","first-page":"6894","DOI":"10.1038\/s41598-025-90150-9","volume":"15","author":"M Mohanad","year":"2025","unstructured":"Mohanad M, Hamza HM, Bahnassy AA, et al. Molecular profiling of breast cancer methylation pattern in triple negative versus non- triple negative breast cancer. Sci Rep. 2025;15(1):6894.","journal-title":"Sci Rep"},{"issue":"1","key":"2052_CR20","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1038\/s41467-025-58158-x","volume":"16","author":"M Aine","year":"2025","unstructured":"Aine M, Nacer DF, Arbajian E, et al. The DNA methylation landscape of primary triple-negative breast cancer. Nat Commun. 2025;16(1):3041.","journal-title":"Nat Commun"},{"issue":"1","key":"2052_CR21","doi-asserted-by":"publisher","first-page":"5758","DOI":"10.1038\/s41467-023-41385-5","volume":"14","author":"KA Tran","year":"2023","unstructured":"Tran KA, Addala V, Johnston RL, et al. Performance of tumour microenvironment deconvolution methods in breast cancer using single-cell simulated bulk mixtures. Nat Commun. 2023;14(1):5758.","journal-title":"Nat Commun"},{"issue":"7","key":"2052_CR22","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2217\/epi-2018-0037","volume":"10","author":"SC Zheng","year":"2018","unstructured":"Zheng SC, Webster AP, Dong D, et al. A novel cell-type deconvolution algorithm reveals substantial contamination by immune cells in saliva, buccal and cervix. Epigenomics. 2018;10(7):925\u201340.","journal-title":"Epigenomics"},{"issue":"1","key":"2052_CR23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12967-022-03736-6","volume":"20","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Wiencke JK, Kelsey KT, et al. HiTIMED: hierarchical tumor immune microenvironment epigenetic deconvolution for accurate cell type resolution in the tumor microenvironment using tumor-type-specific DNA methylation data. J Transl Med. 2022;20(1):516.","journal-title":"J Transl Med"},{"issue":"16","key":"2052_CR24","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1158\/0008-5472.CAN-20-3773","volume":"81","author":"RJ Harris","year":"2021","unstructured":"Harris RJ, Cheung A, Ng JCF, et al. Tumor-infiltrating B lymphocyte Profiling Identifies IgG-biased, clonally expanded prognostic phenotypes in triple-negative breast cancer. Cancer Res. 2021;81(16):4290\u2013304.","journal-title":"Cancer Res"},{"issue":"1","key":"2052_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41523-025-00728-9","volume":"11","author":"H Liang","year":"2025","unstructured":"Liang H, Huang J, Li H, et al. Spatial proximity of CD8+ T cells to tumor cells predicts neoadjuvant therapy efficacy in breast cancer. NPJ Breast Cancer. 2025;11(1):13.","journal-title":"NPJ Breast Cancer"},{"issue":"6","key":"2052_CR26","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.trecan.2024.02.008","volume":"10","author":"VC Rayson","year":"2024","unstructured":"Rayson VC, Harris MA, Savas P, et al. The anti-cancer immune response in breast cancer: current and emerging biomarkers and treatments. Trends Cancer. 2024;10(6):490\u2013506.","journal-title":"Trends Cancer"},{"issue":"1","key":"2052_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12916-023-03233-7","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, Dackus G, Rosenberg EH, et al. Long-term outcomes of young, node-negative, chemotherapy-naive, triple-negative breast cancer patients according to BRCA1 status. BMC Med. 2024;22(1):9.","journal-title":"BMC Med"},{"issue":"10","key":"2052_CR28","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1245\/s10434-013-3205-1","volume":"20","author":"R Greenup","year":"2013","unstructured":"Greenup R, Buchanan A, Lorizio W, et al. Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort. Ann Surg Oncol. 2013;20(10):3254\u20138.","journal-title":"Ann Surg Oncol"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02052-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02052-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02052-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:51:59Z","timestamp":1783039919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13148-026-02052-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2052"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02052-w","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Hunter New England Research Ethics Committee (NSW HREC Reference No: HREC\/09\/HNE\/153), Newcastle, New South Wales and Princess Alexandra Hospital Human Research Ethics Committee (PAH HREC) (Research Protocol: 2007\/165) Brisbane, Queensland. Ethics approval (HREC 2019_ETH12651 was obtained from St Vincent\u2019s Hospital (Sydney) Human Research Ethics Committee (HREC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}